Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Open Access
- 10 November 2011
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 40 (1) , 161-168
Abstract
Information regarding the utility of adjunct diagnostic tests in combination with Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is limited. We hypothesised adjunct tests could enhance accuracy and/or reduce the cost of tuberculosis (TB) diagnosis prior to MTB/RIF testing, and rule-in or rule-out TB in MTB/RIF-negative individuals.We assessed the accuracy and/or laboratory-associated cost of diagnosis of smear microscopy, chest radiography (CXR) and interferon-γ release assays (IGRAs; T-SPOT-TB (Oxford Immunotec, Oxford, UK) and QuantiFERON-TB Gold In-Tube (Cellestis, Chadstone, Australia)) combined with MTB/RIF for TB in 480 patients in South Africa.When conducted prior to MTB/RIF: 1) smear microscopy followed by MTB/RIF (if smear negative) had the lowest cost of diagnosis of any strategy investigated; 2) a combination of smear microscopy, CXR (if smear negative) and MTB/RIF (if imaging compatible with active TB) did not further reduce the cost per TB case diagnosed; and 3) a normal CXR ruled out TB in 18% of patients (57 out of 324; negative predictive value (NPV) 100%). When downstream adjunct tests were applied to MTB/RIF-negative individuals, radiology ruled out TB in 24% (56 out of 234; NPV 100%), smear microscopy ruled in TB in 21% (seven out of 24) of culture-positive individuals and IGRAs were not useful in either context.In resource-poor settings, smear microscopy combined with MTB/RIF had the highest accuracy and lowest cost of diagnosis compared to either technique alone. In MTB/RIF-negative individuals, CXR has poor rule-in value but can reliably rule out TB in approximately one in four cases. These data inform upon the programmatic utility of MTB/RIF in high-burden settings.Keywords
This publication has 16 references indexed in Scilit:
- The Use of an Automated Quantitative Polymerase Chain Reaction (Xpert MTB/RIF) to Predict the Sputum Smear Status of Tuberculosis PatientsClinical Infectious Diseases, 2011
- Xpert MTB/RIF test for tuberculosisThe Lancet, 2011
- Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence SettingAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithmsEuropean Respiratory Journal, 2011
- Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?European Respiratory Journal, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV.2010
- The Effect of Diagnostic Delays on the Drop-Out Rate and the Total Delay to Diagnosis of TuberculosisPLOS ONE, 2008
- Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease.2005
- Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.2003